Inhibition of tumor cell metabolism: Metformin can reduce intracellular glucose levels and insulin signaling, thereby inhibiting the glycolysis process of tumor cells to further weaken the growth and proliferation of glioma cells. This evidence concerns the gene INS and neoplasm.